2022
DOI: 10.2169/internalmedicine.7176-21
|View full text |Cite
|
Sign up to set email alerts
|

Immune Reconstitution Inflammatory Syndrome Associated with <i>Pneumocystis jirovecii</i> Pneumonia and Cytomegalovirus Colitis in a Patient with Rheumatoid Arthritis

Abstract: A 68-year-old woman presenting with rheumatoid arthritis was admitted due to pancytopenia caused by methotrexate. Pneumocystis jirovecii pneumonia was diagnosed based on the abnormal shadows observed on chest computed tomography, the presence of serum β-D-glucan, and positive P. jirovecii-DNA results in a sputum analysis. Subsequently, after treatment with leucovorin and trimethoprim-sulfamethoxazole, lung consolidation was found to be aggravated, along with a rapidly increasing leukocyte count. In addition, c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…This case highlights the potential risks of immunosuppression in RA, stressing the importance of careful monitoring and possibly preemptive measures during immunosuppressive therapy. 6 A report covered the reactivation of cytomegalovirus in a patient with refractory rheumatoid vasculitis, considered a manifestation of immune reconstitution inflammatory syndrome (IRIS). It discusses the impact of adjusting immunosuppressive therapy on the course of both vasculitis and viral reactivation.…”
Section: Discussionmentioning
confidence: 99%
“…This case highlights the potential risks of immunosuppression in RA, stressing the importance of careful monitoring and possibly preemptive measures during immunosuppressive therapy. 6 A report covered the reactivation of cytomegalovirus in a patient with refractory rheumatoid vasculitis, considered a manifestation of immune reconstitution inflammatory syndrome (IRIS). It discusses the impact of adjusting immunosuppressive therapy on the course of both vasculitis and viral reactivation.…”
Section: Discussionmentioning
confidence: 99%